Esperante BV - Company Review
Esperante BV - Company ReviewSummary
Esperante BV (Esperante) is a venture capital firm that invests in the therapeutics development companies. The firm invests in companies, which provides drug development for orphan indications; vitro diagnostic and biomarker tests for clinical indications and marketing of pharma products in different therapeutic indications. Its investment portfolio companies include Altacor, Cytox, Anergis, Altimmune, Endocells, Cara Therapeutics and AtoxBio, among others. Esperante invests in companies operating in the US, continental Europe, the UK, and Israel. The firms investment ranges from EUR 300,000 and EUR 700,000. It has operations in the Netherlands and the UK. Esperante is headquartered in Hoofddorp, The Netherlands.
This comprehensive company report of Esperante BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.